Methodological & Statistical Research Subcategories
Artificial Intelligence, Machine Learning, Predictive Analytics Reports
Modeling, Simulation, Optimization
-
Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey
-
Application of Constrained Optimization Methods in Health Services Research
-
Constrained Optimization Methods in Health Services Research-An Introduction
-
Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research - The SIMULATE Checklist
-
Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research - Part 2
-
Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making - Report 2
-
Modeling Good Research Practices - Overview: Report 1
-
Conceptualizing a Model: Report 2
-
State-Transition Modeling: Report 3
-
Modeling Using Discrete Event Simulation: Report 4
-
Dynamic Transmission Modeling: Report 5
-
Model Parameter Estimation and Uncertainty Analysis: Report 6
-
Model Transparency and Validation: Report 7
-
Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation
Preference Methods
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions - Report of the ISPOR Stated Preference Research Special Interest Group
-
Statistical Methods for the Analysis of Discrete-Choice Experiments
-
Constructing Experimental Designs for Discrete-Choice Experiments
-
Conjoint Analysis Applications in Health - A Checklist
-
Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy - Report of ISPOR Risk–Benefit Management Working Group
PRO & Related Methods
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
-
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials
-
Clinician-Reported Outcome Assessments of Treatment Benefit-Clinical Outcome Assessment Emerging Good Practices Task Force
-
Clinical Outcome Assessments: A Conceptual Foundation Good Practices for Outcomes Research Task Force
-
PRO Data Collection in Clinical Trials Using Mixed Modes
-
Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling
-
Validation of Electronic Systems to Collect Patient-Reported Outcome (PRO) Data - Recommendations for Clinical Trial Teams
-
Content Validity - Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 1
-
Content Validity – Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 2
-
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification
-
Multinational Trials – Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data
-
Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures
-
Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures
All Methodological & Statistical Research Reports
Please Note: Reports are in reverse chronological order.
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
Machine Learning Methods in Health Economics and Outcomes Research—The PALISADE Checklist
-
Accounting For Preference Heterogeneity In Discrete-Choice Experiments
-
Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey
-
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions - Report of the ISPOR Stated Preference Research Special Interest Group
-
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models
-
Application of Constrained Optimization Methods in Health Services Research
-
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials
-
Constrained Optimization Methods in Health Services Research-An Introduction
-
Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures
-
Clinician-Reported Outcome Assessments of Treatment Benefit-Clinical Outcome Assessment Emerging Good Practices Task Force
-
Estimating Health-State Utility for Economic Models in Clinical Studies
-
Statistical Methods for the Analysis of Discrete-Choice Experiments
-
Clinical Outcome Assessments: A Conceptual Foundation Good Practices for Outcomes Research Task Force
-
Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research - The SIMULATE Checklist
-
Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research - Part 2
-
PRO Data Collection in Clinical Trials Using Mixed Modes
-
A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making - Report 1
-
Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making - Report 2
-
Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling
-
Validation of Electronic Systems to Collect Patient-Reported Outcome (PRO) Data - Recommendations for Clinical Trial Teams
-
Constructing Experimental Designs for Discrete-Choice Experiments
-
Modeling Good Research Practices - Overview: Report 1
-
Conceptualizing a Model: Report 2
-
State-Transition Modeling: Report 3
-
Modeling Using Discrete Event Simulation: Report 4
-
Dynamic Transmission Modeling: Report 5
-
Model Parameter Estimation and Uncertainty Analysis: Report 6
-
Model Transparency and Validation: Report 7
-
Content Validity - Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 1
-
Content Validity – Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 2
-
Conjoint Analysis Applications in Health - A Checklist
-
Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy - Report of ISPOR Risk–Benefit Management Working Group
-
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification
-
Multinational Trials – Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data
-
Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures
-
Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures
-
Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation